Easybio

Market position

EASY BIO is described as a leading South Korean animal nutrition company and is classified in the animal feed sector, where MarketScreener lists peers including Guangdong Haid Group, New Hope Liuhe, PT Charoen Pokphand Indonesia, Schouw & Co., Beijing Dabeinong, Fujian Aonong, Avanti Feeds, Guangdong Yuehai Feeds and Wellhope Foods. Its market capitalisation of about USD 157 million is well below the roughly USD 2.8 billion sector average of that peer group.

EASY BIO positions its offering around functional feed additives combining its own nutrient absorption enhancer, Lipidol, with polysaccharide-based nutrient coating technology acquired with BioMatrix, which is described as offering greater stability and effectiveness than conventional fat-coating methods by enabling nutrients to reach their intended site of action. The company also cites a portfolio spanning antibiotic alternatives, cost reduction and livestock gut health.

Technology

The company develops functional feed additives, including Lipidol, a nutrient absorption enhancer developed by EASY BIO and Pathway USA, and Lipidol Protect, which pairs Lipidol with BioMatrix's polysaccharide-based coating technology. The coating protects nutrients that would otherwise be degraded by microorganisms in the animal gastrointestinal tract and is stated to provide better stability and effectiveness than conventional fat-coating approaches. R&D focus areas include antibiotic alternatives, feed cost reduction and livestock gut health.

Go-to-market

Products are sold in domestic Korean and overseas markets through the company's own operations and through international subsidiaries, including Pathway Intermediates entities in six countries and acquired North American businesses that bring local distribution experience and networks.

Livestock producers and farms, including swine, poultry and ruminant (cattle) operations, together with business partners and distributors; the acquired BioMatrix business also serves the companion animal additives market.

Geography

Headquartered at Union Center, Seoul, South Korea, with sales in both domestic and overseas markets. South Korea accounted for KRW 129 billion of sales in 2021 and KRW 156 billion in 2022. International operations include Pathway feed additive subsidiaries in six countries, Pathway Intermediates USA, Devenish North America and BioMatrix in Princeton, Minnesota; products such as Lipidol Protect are sold in the United States and the United Kingdom.

History

The company was established in 1988 in Seoul and has focused on technological innovation in antibiotic alternatives, cost reduction and gut health solutions for livestock. It set up Pathway Intermediates USA in 2019 and has since built Pathway feed additive subsidiaries in six countries. In 2023 it launched Lipidol Protect in collaboration with BioMatrix. In 2025 it acquired Devenish North America from Devenish Holdings of Northern Ireland, and on 2 January 2026 it announced the acquisition of a 100 percent stake in Minnesota-based BioMatrix through Pathway Intermediates USA. Jae-Won Kim became CEO in March 2023, serving alongside CEO Il-Hwan Hwang; Hyun-Wook Ji has been chairman since March 2022.